Amphastar Pharmaceuticals Files Definitive Proxy Statement
Ticker: AMPH · Form: DEFA14A · Filed: 2024-04-12T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, annual-meeting
TL;DR
Amphastar filed its proxy statement for the annual meeting - shareholders vote soon!
AI Summary
Amphastar Pharmaceuticals, Inc. filed a definitive proxy statement on April 12, 2024, for its annual meeting of stockholders. The filing indicates that Amphastar is a pharmaceutical preparations company located in Rancho Cucamonga, CA, and is subject to the 1934 Securities Exchange Act.
Why It Matters
This filing is important for shareholders as it contains information about the company's annual meeting, including proposals to be voted on and details about director nominations and executive compensation.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) that provides information to shareholders and does not inherently indicate new risks for the company.
Key Players & Entities
- Amphastar Pharmaceuticals, Inc. (company) — Registrant
- 2834 (dollar_amount) — Standard Industrial Classification for Pharmaceutical Preparations
- 330702205 (dollar_amount) — IRS Number
- 1231 (dollar_amount) — Fiscal Year End
- 001-36509 (dollar_amount) — SEC File Number
- 24841615 (dollar_amount) — Film Number
- 11570 SIXTH STREET (dollar_amount) — Business Street Address
- RANCHO CUCAMONGA (dollar_amount) — Business City
- CA (dollar_amount) — Business State
- 91730 (dollar_amount) — Business Zip Code
FAQ
What type of filing is this DEFA14A for Amphastar Pharmaceuticals?
This is a Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing made?
The filing was made on April 12, 2024.
What is Amphastar Pharmaceuticals' Standard Industrial Classification code?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Amphastar Pharmaceuticals, Inc. located?
The company's business address is 11570 Sixth Street, Rancho Cucamonga, CA 91730.
What is the SEC file number for Amphastar Pharmaceuticals?
The SEC file number is 001-36509.
Filing Stats: 111 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-04-12 16:14:10
Filing Documents
- amph-20240412xdefa14a.htm (DEFA14A) — 16KB
- amph-20240412xdefa14a001.jpg (GRAPHIC) — 232KB
- amph-20240412xdefa14a002.jpg (GRAPHIC) — 180KB
- 0001297184-24-000022.txt ( ) — 585KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 AMPHASTAR PHARMACEUTICALS, INC. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(4) and 0-11.